Management of QED Connect, Inc. (OTC Pink:QEDN) today announced that Emerald Med Farms will be complimenting the management team, with the addition of Mr. Thomas Szabo, PHD. In April 2014, the Company entered into an agreement to acquire 100% of Emerald Med Farms, Inc., a California based medical marijuana company. He brings his extensive research experience in biotech, pharmaceutical industry, and academia in the synthesis of small molecule libraries, nucleoside and nucleotide chemistry, solution- and solid-phase structural characterizations, assay development, characterization by NMR/MS, medicinal chemistry, automated prep-LCMS, SAR.

Mr. Szabo received a PhD in Organic Chemistry from Stockholm University. He was a Postdoctoral Research Associate in the development of methods for modular assembly of molecular capsules at Massachusetts Institute of Technology. Mr. Szabo also did Postdoctoral Research for the design, synthesis, and structural studies of self-assembling molecules at Scripps Research Institute, Lo Jolla CA.

Mr. Szabo commented, "I am very excited to be involved in the medical marijuana industry during its early stages of development. I believe that we will be able to improve the quality of the product for the user and improve the yield of the crops. As the industry matures and increased regulations are enacted it will be important to be able to control the growing cycle to assure we meet or exceed these standards."

Mr. Steven Amano, GM and VP of Operations for Emerald Med Farms, added, "With the addition of Thomas, we will have a solid team to assist us in executing our plan to be a major supplier. Emerald Med Farms plans to develop a state-of-the-art facility which will utilize multi-state experience and proven methods to produce the highest of quality medical cannabis. It is our intention to be a leader providing improved products as this industry becomes a major component of the medical industry."

About QED Connect, Inc.

QED Connect, Inc. is a holding company which makes acquisitions, investments, and enters into strategic business partnerships. The Company works with organizations that are looking for capital, management assistance, or help in reaching their target markets to realize their true potential. QED acquired In April 2014, the Company entered into an agreement to acquire Emerald Med Farms, Inc., a California based medical marijuana company. QED's business model helps to achieve its goals by expanding its overall revenue and profits potential through multiple market segments.

Safe Harbor Statement

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as "anticipate," "believe," "expect," "future," "may," "will," "would," "should," "plan," "projected," "intend," and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of QED to be materially different from those expressed or implied by such forward-looking statements. QED's future operating results are dependent upon many factors, including but not limited to the Company's ability to: (i) obtain sufficient capital or a strategic business arrangement to fund its expansion plans; (ii) build the management infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company's control; and (iv) other risk factors.

CONTACT: For more information contact:
         Tom Makmann
         Tel: (603) 425-8933
         Fax: (561) 764-6180
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more QED Connect (PK) Charts.
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more QED Connect (PK) Charts.